Rhodes Jason P's Form 4 filing
Dyne Therapeutics, Inc. (DYN) · filed Jun 30, 2026
- Accession no.
- 0001577014-26-000012
- Filed
- Jun 30, 2026
- Trade date
- Jun 26-29, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $10.7M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rhodes Jason PCIK 0001577014 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Common Stock | SSaleDisposed | −162,954 | $21.28 | −$3,467,661.12 | 4,579,456 | Indirect | |
| Jun 26, 2026 | Common Stock | SSaleDisposed | −81,903 | $21.28 | −$1,742,895.84 | 1,396,475 | Indirect | |
| Jun 26, 2026 | Common Stock | SSaleDisposed | −64,411 | $21.28 | −$1,370,666.08 | 1,016,633 | Indirect | |
| Jun 29, 2026 | Common Stock | SSaleDisposed | −102,969 | $21.14 | −$2,176,764.66 | 4,476,487 | Indirect | |
| Jun 29, 2026 | Common Stock | SSaleDisposed | −51,756 | $21.14 | −$1,094,121.84 | 1,344,719 | Indirect | |
| Jun 29, 2026 | Common Stock | SSaleDisposed | −40,702 | $21.14 | −$860,440.28 | 975,931 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.